Recent publications · Crossref
5 total works indexed
- Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
· 2019 · cited 2,835x
- Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
· 2018 · cited 1,112x
- Human NK Cell Education by Inhibitory Receptors for MHC Class I
· 2006 · cited 1,000x
- International meta-analysis of PTSD genome-wide association studies identifies sex- and ancestry-specific genetic risk loci
· 2019 · cited 602x
- Impact of Platelet Reactivity After Clopidogrel Administration on Drug-Eluting Stent Thrombosis
· 2007 · cited 522x
via Crossref · CC0